FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lisa Costello-Boerrigter

Research Profile

Chemicals & Drugs

Disorders

Anatomy

Kidneys

Living Beings

Dogs

Concepts & Ideas

Physiology

Phenomena

Renal Circulation

Co-author Network

Publications

TOP 3
Sarah Mangiafico; Ingrid A Andersen; Alessandro Cataliotti; Lisa C Costello-Boerrigter; John C Burnett
Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics.
Fima Macheret; Lorenzo Malatino; Sarah Mangiafico; Paul McKie; Margaret M Redfield; Richard Rodeheffer; Sharon Sandberg; Christopher G Scott; Kent Bailey; Diego Bellavia; Guido Boerrigter; John Burnett; Horng H Chen; Lisa C Costello-Boerrigter; Denise M Heublein; Yasuhiro Ikeda; Alessandro Cataliotti
Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP.
Lisa C Costello-Boerrigter
Cardiac natriuretic peptides: contributors to cardiac cachexia or possible anti-obesity agents or both?

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lisa Costello-Boerrigter (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sarah Mangiafico; Ingrid A Andersen; Alessandro Cataliotti; Lisa C Costello-Boerrigter; John C Burnett
Neutral endopeptidase inhibition and the natriuretic peptide system: an evolving strategy in cardiovascular therapeutics.
European heart journal 2013;34(12):886-893c.
2012: Fima Macheret; Lorenzo Malatino; Sarah Mangiafico; Paul McKie; Margaret M Redfield; Richard Rodeheffer; Sharon Sandberg; Christopher G Scott; Kent Bailey; Diego Bellavia; Guido Boerrigter; John Burnett; Horng H Chen; Lisa C Costello-Boerrigter; Denise M Heublein; Yasuhiro Ikeda; Alessandro Cataliotti
Human hypertension is characterized by a lack of activation of the antihypertensive cardiac hormones ANP and BNP.
Journal of the American College of Cardiology 2012;60(16):1558-65.
2012: Lisa C Costello-Boerrigter
Cardiac natriuretic peptides: contributors to cardiac cachexia or possible anti-obesity agents or both?
Diabetes 2012;61(10):2403-4.
2012: Alessandro Cataliotti; Horng H Chen; Lisa C Costello-Boerrigter; Stephen C Textor; John C Burnett
Sustained blood pressure-lowering actions of subcutaneous B-type natriuretic peptide (nesiritide) in a patient with uncontrolled hypertension.
Mayo Clinic proceedings. Mayo Clinic 2012;87(4):413-5.
2011: Lisa C Costello-Boerrigter; John C Burnett
Controlling the flood gates: vaptans, furosemide and the quest for a renal protective diuresis.
Journal of cardiac failure 2011;17(12):990-2.
2011: Paul M McKie; Margaret M Redfield; John A Schirger; Robert D Simari; Kent R Bailey; Sherry L Benike; John C Burnett; Lisa C Costello-Boerrigter; Lynn K Harstad; David O Hodge; Horng H Chen
Impaired natriuretic and renal endocrine response to acute volume expansion in pre-clinical systolic and diastolic dysfunction.
Journal of the American College of Cardiology 2011;58(20):2095-103.
2011: Valentina Cannone; Alessandro Cataliotti; Lisa C Costello-Boerrigter; Denise M Heublein; Brian D Lahr; Paul M McKie; Timothy M Olson; Margaret M Redfield; Richard J Rodeheffer; Maurizio Averna; Kent R Bailey; Guido Boerrigter; John C Burnett
A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community.
Journal of the American College of Cardiology 2011;58(6):629-36.
2011: Lisa C Costello-Boerrigter; John C Burnett
Heart failure: furosemide--to DOSE or not to DOSE, that is the question.
Nature reviews. Cardiology 2011;8(7):365-6.
2011: Fima Macheret; Guido Boerrigter; Paul McKie; Lisa C Costello-Boerrigter; Brian Lahr; Denise M Heublein; Sharon Sandberg; Yasuhiro Ikeda; Alessandro Cataliotti; Kent Bailey; Richard J Rodeheffer; John C Burnett
Pro-B-type natriuretic peptide(1-108) circulates in the general community: plasma determinants and detection of left ventricular dysfunction.
Journal of the American College of Cardiology 2011;57(12):1386-95.
2011: Lisa C Costello-Boerrigter; Guido Boerrigter; Syed Ameenuddin; Douglas W Mahoney; Joshua P Slusser; Denise M Heublein; Margaret M Redfield; Richard J Rodeheffer; Timothy M Olson; John C Burnett
The effect of the brain-type natriuretic peptide single-nucleotide polymorphism rs198389 on test characteristics of common assays.
Mayo Clinic proceedings. Mayo Clinic 2011;86(3):210-8.
2010: Lisa C Costello-Boerrigter; Guido Boerrigter; Alessandro Cataliotti; Gail J Harty; John C Burnett
Renal and anti-aldosterone actions of vasopressin-2 receptor antagonism and B-type natriuretic peptide in experimental heart failure.
Circulation. Heart failure 2010;3(3):412-9.
2009: Guido Boerrigter; Lisa C Costello-Boerrigter; John C Burnett
Natriuretic peptides in the diagnosis and management of chronic heart failure.
Heart failure clinics 2009;5(4):501-14.
2009: Lisa C Costello-Boerrigter; John C Burnett
A new role for the natriuretic peptides: metabolic regulators of the adipocyte.
Journal of the American College of Cardiology 2009;53(22):2078-9.
2009: Guido Boerrigter; Lisa C Costello-Boerrigter; Gail J Harty; Brenda K Huntley; Alessandro Cataliotti; Harald Lapp; John C Burnett
B-type natriuretic peptide 8-32, which is produced from mature BNP 1-32 by the metalloprotease meprin A, has reduced bioactivity.
American journal of physiology. Regulatory, integrative and comparative physiology 2009;296(6):R1744-50.
2009: Lisa C Costello-Boerrigter; Guido Boerrigter; John C Burnett
Pharmacology of vasopressin antagonists.
Heart failure reviews 2009;14(2):75-82.
2008: Alessandro Cataliotti; Horng H Chen; John A Schirger; Fernando L Martin; Guido Boerrigter; Lisa C Costello-Boerrigter; Kenneth D James; Karen Polowy; Mark A Miller; Navdeep B Malkar; kent bailey; John C Burnett
Chronic actions of a novel oral B-type natriuretic peptide conjugate in normal dogs and acute actions in angiotensin II-mediated hypertension.
Circulation 2008;118(17):1729-36.
2008: Guido Boerrigter; Lisa C Costello-Boerrigter; William T Abraham; Martin G St John Sutton; Denise M Heublein; Kristin M Kruger; Michael R S Hill; Peter A McCullough; John C Burnett
Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate.
Journal of cardiac failure 2008;14(7):539-46.
2007: Lisa C Costello-Boerrigter; Guido Boerrigter; John C Burnett
V2 receptor antagonism with tolvaptan in heart failure.
Expert opinion on investigational drugs 2007;16(10):1639-47.
2007: Lisa C Costello-Boerrigter; Guido Boerrigter; Gail J Harty; Alessandro Cataliotti; Margaret M Redfield; John C Burnett
Mineralocorticoid escape by the kidney but not the heart in experimental asymptomatic left ventricular dysfunction.
Hypertension 2007;50(3):481-8.
2007: Guido Boerrigter; Lisa C Costello-Boerrigter; Alessandro Cataliotti; Harald Lapp; Johannes-Peter Stasch; John C Burnett
Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure.
Hypertension 2007;49(5):1128-33.
2007: Carolyn S P Lam; John C Burnett; Lisa C Costello-Boerrigter; Richard J Rodeheffer; Margaret M Redfield
Alternate circulating pro-B-type natriuretic peptide and B-type natriuretic peptide forms in the general population.
Journal of the American College of Cardiology 2007;49(11):1193-202.
2007: Guido Boerrigter; Lisa C Costello-Boerrigter; Gail J Harty; Harald Lapp; John C Burnett
Des-serine-proline brain natriuretic peptide 3-32 in cardiorenal regulation.
American journal of physiology. Regulatory, integrative and comparative physiology 2007;292(2):R897-901.
2006: Lisa C Costello-Boerrigter; William B Smith; Guido Boerrigter; John Ouyang; Christopher A Zimmer; Cesare Orlandi; John C Burnett
Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure.
American journal of physiology. Renal physiology 2006;290(2):F273-8.
2006: Lisa C Costello-Boerrigter; Guido Boerrigter; Margaret M Redfield; Richard J Rodeheffer; Lynn H Urban; Douglas W Mahoney; Steven J Jacobsen; Denise M Heublein; John C Burnett
Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.
Journal of the American College of Cardiology 2006;47(2):345-53.
2005: Alessandro Cataliotti; John A Schirger; Fernando L Martin; Horng H Chen; Paul M McKie; Guido Boerrigter; Lisa C Costello-Boerrigter; Gail J Harty; Denise M Heublein; Sharon M Sandberg; Kenneth D James; Mark A Miller; Navdeep B Malkar; Karen Polowy; John C Burnett
Oral human brain natriuretic peptide activates cyclic guanosine 3',5'-monophosphate and decreases mean arterial pressure.
Circulation 2005;112(6):836-40.
2005: Lisa C Costello-Boerrigter; John C Burnett
The prognostic value of N-terminal proB-type natriuretic peptide.
Nature clinical practice. Cardiovascular medicine 2005;2(4):194-201.
2004: Alessandro Cataliotti; Guido Boerrigter; Lisa C Costello-Boerrigter; John A Schirger; Toshihiro Tsuruda; Denise M Heublein; Horng H Chen; Lorenzo S Malatino; John C Burnett
Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
Circulation 2004;109(13):1680-5.
2004: Harald Lapp; Guido Boerrigter; Lisa C Costello-Boerrigter; Karsten Jaekel; Thomas Scheffold; Ingo Krakau; Matthias Schramm; Hartmut Guelker; Johannes-Peter Stasch
Elevated plasma human urotensin-II-like immunoreactivity in ischemic cardiomyopathy.
International journal of cardiology 2004;94(1):93-7.
2004: Toshihiro Tsuruda; Lisa C Costello-Boerrigter; John C Burnett
Matrix metalloproteinases: pathways of induction by bioactive molecules.
Heart failure reviews 2004;9(1):53-61.
2003: Toshihiro Tsuruda; Michihisa Jougasaki; Guido Boerrigter; Lisa C Costello-Boerrigter; Alessandro Cataliotti; Shang C Lee; Lisa Salz-Gilman; Lynda J Nordstrom; Christopher G A McGregor; John C Burnett
Ventricular adrenomedullin is associated with myocyte hypertrophy in human transplanted heart.
Regulatory peptides 2003;112(1-3):161-6.
2003: Lisa C Costello-Boerrigter; Guido Boerrigter; John C Burnett
Revisiting salt and water retention: new diuretics, aquaretics, and natriuretics.
The Medical clinics of North America 2003;87(2):475-91.
2003: Guido Boerrigter; Lisa C Costello-Boerrigter; Alessandro Cataliotti; Toshihiro Tsuruda; Gail J Harty; Harald Lapp; Johannes-Peter Stasch; John C Burnett
Cardiorenal and humoral properties of a novel direct soluble guanylate cyclase stimulator BAY 41-2272 in experimental congestive heart failure.
Circulation 2003;107(5):686-9.
2002: Toshihiro Tsuruda; Guido Boerrigter; Brenda K Huntley; Josh A Noser; Alessandro Cataliotti; Lisa C Costello-Boerrigter; Horng H Chen; John C Burnett
Brain natriuretic Peptide is produced in cardiac fibroblasts and induces matrix metalloproteinases.
Circulation research 2002;91(12):1127-34.